BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33552352)

  • 1. [The association of stromal mesenchymal cells with the bone substitute for the treatment of non-union of long bones, an alternative to autologous spongy grafts: a case report].
    Chagou A; Benameur H; Hassoun J; Abdeloihab J
    Pan Afr Med J; 2020; 37():234. PubMed ID: 33552352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone regeneration strategies with bone marrow stromal cells in orthopaedic surgery.
    Stanovici J; Le Nail LR; Brennan MA; Vidal L; Trichet V; Rosset P; Layrolle P
    Curr Res Transl Med; 2016; 64(2):83-90. PubMed ID: 27316391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of autologous or allogeneic mesenchymal stromal cells from adult adipose tissue expanded and combined with tricalcium phosphate biomaterial for the surgical treatment of atrophic nonunion of long bones: a phase II clinical trial.
    Orozco Delclós L; Soler Rich R; Arriaza Loureda R; Moreno García A; Gómez Barrena E
    J Transl Med; 2024 May; 22(1):493. PubMed ID: 38789992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orthopaedic applications of bone graft & graft substitutes: a review.
    Nandi SK; Roy S; Mukherjee P; Kundu B; De DK; Basu D
    Indian J Med Res; 2010 Jul; 132():15-30. PubMed ID: 20693585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of six bone-graft substitutes regarding to cell seeding efficiency, metabolism and growth behaviour of human mesenchymal stem cells (MSC) in vitro.
    Seebach C; Schultheiss J; Wilhelm K; Frank J; Henrich D
    Injury; 2010 Jul; 41(7):731-8. PubMed ID: 20233614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Study on the Application of Mesenchymal Stromal Cells Combined with Tricalcium Phosphate Scaffold into Femoral Bone Defects.
    Šponer P; Kučera T; Brtková J; Urban K; Kočí Z; Měřička P; Bezrouk A; Konrádová Š; Filipová A; Filip S
    Cell Transplant; 2018 Oct; 27(10):1459-1468. PubMed ID: 30203687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of non-hypertrophic pseudoarthrosis of long bones with a Tissue Engineered Product loaded with autologous bone marrow-derived Mesenchymal Stromal Cells: Results from a phase IIa, prospective, randomized, parallel, pilot clinical trial comparing to iliac crest autograft.
    Chaverri D; Gallardo-Villares S; Pinto JA; Rodríguez L; Codinach M; García-López J; Querol S; Coll R; Vives J; Granell-Escobar F
    Injury; 2024 Jul; 55(7):111596. PubMed ID: 38797000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early efficacy evaluation of mesenchymal stromal cells (MSC) combined to biomaterials to treat long bone non-unions.
    Gómez-Barrena E; Padilla-Eguiluz N; Rosset P; Gebhard F; Hernigou P; Baldini N; Rouard H; Sensebé L; Gonzalo-Daganzo RM; Giordano R; García-Rey E; Cordero-Ampuero J; Rubio-Suárez JC; García-Simón MD; Stanovici J; Ehrnthaller C; Huber-Lang M; Flouzat-Lachaniette CH; Chevallier N; Donati DM; Spazzoli B; Ciapetti G; Fleury S; Fernandez MN; Cabrera JR; Avendaño-Solá C; Montemurro T; Panaitescu C; Veronesi E; Rojewski MT; Lotfi R; Dominici M; Schrezenmeier H; Layrolle P
    Injury; 2020 Apr; 51 Suppl 1():S63-S73. PubMed ID: 32139130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A method of treatment for nonunion after fractures using mesenchymal stromal cells loaded on collagen microspheres and incorporated into platelet-rich plasma clots.
    Wittig O; Romano E; González C; Diaz-Solano D; Marquez ME; Tovar P; Aoun R; Cardier JE
    Int Orthop; 2016 May; 40(5):1033-8. PubMed ID: 26980620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guided bone regeneration in pig calvarial bone defects using autologous mesenchymal stem/progenitor cells - a comparison of different tissue sources.
    Stockmann P; Park J; von Wilmowsky C; Nkenke E; Felszeghy E; Dehner JF; Schmitt C; Tudor C; Schlegel KA
    J Craniomaxillofac Surg; 2012 Jun; 40(4):310-20. PubMed ID: 21723141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stem cells for bone repair: preclinical studies and potential orthopedic applications.
    Arinzeh TL
    Foot Ankle Clin; 2005 Dec; 10(4):651-65, viii. PubMed ID: 16297825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of a long bone fracture non-union healing score after treatment with mesenchymal stromal cells combined to biomaterials.
    Gómez-Barrena E; Padilla-Eguiluz NG; García-Rey E; Hernández-Esteban P; Cordero-Ampuero J; Rubio-Suárez JC;
    Injury; 2020 Apr; 51 Suppl 1():S55-S62. PubMed ID: 32081389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem cells: mechanisms and role in bone regeneration.
    Qin Y; Guan J; Zhang C
    Postgrad Med J; 2014 Nov; 90(1069):643-7. PubMed ID: 25335795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chondrogenically differentiated mesenchymal stromal cell pellets stimulate endochondral bone regeneration in critical-sized bone defects.
    van der Stok J; Koolen MK; Jahr H; Kops N; Waarsing JH; Weinans H; van der Jagt OP
    Eur Cell Mater; 2014 Feb; 27():137-48; discussion 148. PubMed ID: 24554271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autogenous injectable bone for regeneration with mesenchymal stem cells and platelet-rich plasma: tissue-engineered bone regeneration.
    Yamada Y; Ueda M; Naiki T; Takahashi M; Hata K; Nagasaka T
    Tissue Eng; 2004; 10(5-6):955-64. PubMed ID: 15265313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clumps of a mesenchymal stromal cell/extracellular matrix complex can be a novel tissue engineering therapy for bone regeneration.
    Kittaka M; Kajiya M; Shiba H; Takewaki M; Takeshita K; Khung R; Fujita T; Iwata T; Nguyen TQ; Ouhara K; Takeda K; Fujita T; Kurihara H
    Cytotherapy; 2015 Jul; 17(7):860-73. PubMed ID: 25743634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous adipose tissue-derived stem cells induce persistent bone-like tissue in osteonecrotic femoral heads.
    Pak J
    Pain Physician; 2012; 15(1):75-85. PubMed ID: 22270740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What should be the characteristics of the ideal bone graft substitute? Combining scaffolds with growth factors and/or stem cells.
    Janicki P; Schmidmaier G
    Injury; 2011 Sep; 42 Suppl 2():S77-81. PubMed ID: 21724186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous bone marrow stromal cells are promising candidates for cell therapy approaches to treat bone degeneration in sickle cell disease.
    Lebouvier A; Poignard A; Coquelin-Salsac L; Léotot J; Homma Y; Jullien N; Bierling P; Galactéros F; Hernigou P; Chevallier N; Rouard H
    Stem Cell Res; 2015 Nov; 15(3):584-594. PubMed ID: 26492634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone Regeneration Using the Freshly Isolated Autologous Stromal Vascular Fraction of Adipose Tissue in Combination With Calcium Phosphate Ceramics.
    Prins HJ; Schulten EA; Ten Bruggenkate CM; Klein-Nulend J; Helder MN
    Stem Cells Transl Med; 2016 Oct; 5(10):1362-1374. PubMed ID: 27388241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.